Τετάρτη 7 Αυγούστου 2019


A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Sickle cell disease affects approximately 100,000 persons in the United States and reduces life expectancy by approximately 30 years. The disease is caused by a single amino acid substitution resulting in the production of sickle hemoglobin (HbS). HbS polymerizes when deoxygenated, resulting in…
The New England Journal of Medicine: Search Results in Hematology\Oncology
2m
Abortion Rights in Peril — What Clinicians Need to Know
This year, 2019, has become a critical time for abortion rights, with an unprecedented surge of abortion bans sweeping across the United States. Through June 1, some 26 abortion bans have been enacted in 12 states, and many more have been introduced by state legislators. Yet state efforts to…
The New England Journal of Medicine: Search Results in Health Policy and Reform
9m

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου